{"lastClose": 7.099999904632568, "len": 1093, "date": "2023-02-14", "alpha_1": -0.1393342624716487, "beta_1": 1.6550007383477585, "drawup_1": 1.5486725887776869, "natr_1": 12.439373179673092, "sup_1": -0.5126760891929064, "res_1": 0.33943664755982395, "bullPattern_1": ["HAMMER"], "bearPattern_1": [], "rsi_1": 57.50332107910342, "adx_1": 36.64968918885121, "drawdown_1": -0.674768538064794, "stratHoldSharpe_1": -0.08855983484685277, "stratHoldAlpha_1": 250.9385903398346, "stratHoldDrawdown_1": -0.634078571489735, "alpha_3mo": -0.7542965354134871, "beta_3mo": 2.068373183508729, "drawup_3mo": 0.4608541290620036, "natr_3mo": 12.439373179673092, "sup_3mo": -0.10140842251587481, "res_3mo": 0.04366196435823527, "bullPattern_3mo": ["DOJI", "HIGHWAVE", "LONGLEGGEDDOJI", "RICKSHAWMAN", "SPINNINGTOP"], "bearPattern_3mo": ["HARAMI", "HARAMICROSS"], "rsi_3mo": 33.81818143986467, "adx_3mo": 27.7666465069053, "drawdown_3mo": -0.4781801627958294, "stratHoldSharpe_3mo": -1.7417387252943803, "stratHoldAlpha_3mo": 249.90205225970632, "stratHoldDrawdown_3mo": -0.4334206402188253, "Sector": "Health Care", "Market Cap": 1028939449, "Country": "United States", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Name": "Allogene Therapeutics Inc.", "IPO Year": 2018.0, "alpha%_1": 0.4355495946494322, "beta%_1": 0.9033051885629082, "drawup%_1": 0.9973928343467121, "natr%_1": 0.9999128698280085, "drawdown%_1": 0.07205981675215778, "stratHoldSharpe%_1": 0.3559233027237231, "stratHoldAlpha%_1": 0.31397285127660074, "stratHoldDrawdown%_1": 0.06019105011044874, "alpha%_3mo": 0.07040154820132703, "beta%_3mo": 0.9761434991229359, "drawup%_3mo": 0.8871119266982233, "natr%_3mo": 0.999864606148778, "drawdown%_3mo": 2.8060149913235497e-05, "stratHoldSharpe%_3mo": 0.03908402325450344, "stratHoldAlpha%_3mo": 0.0036663408171883757, "stratHoldDrawdown%_3mo": 2.5212669542915836e-05}